Cash Flow

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
Sep. 30, 2025 Sep. 30, 2024
Cash flows from operating activities
Net loss $ (163,778) $ (224,458)
Adjustments to reconcile net loss to net cash used in operating activities
Equity-based compensation 12,668 8,637
Change in fair value of warrants 1,881 54,532
Change in fair value of derivative (3,443) 395
Depreciation expense 21,875 23,853
Amortization of debt issuance costs and debt discounts 17,335 10,505
Accretion of discount on debt securities 0 (330)
Operating lease amortization expense 3,398 2,281
Loss on extinguishment of debt 0 21,214
Loss on disposal of equipment 3,765 0
Impairment of operating right-of-use asset 0 757
Other 938 0
Changes in operating assets and liabilities
Accounts receivable (1,595) 0
Inventory (2,638) (1,829)
Prepaid expenses and other current assets (1,779) (347)
Prepaid expenses and other noncurrent assets 968 (63)
Accounts payable (2,062) 675
Accrued expenses and other current liabilities (578) (3,379)
Accrued interest 1,820 (3,334)
Other noncurrent liabilities 0 33
Operating lease right-of-use liabilities (2,827) (2,127)
Net cash used in operating activities (114,054) (112,985)
Cash flows from investing activities
Purchase of property, plant and equipment (27,504) (33,989)
Purchase of debt securities, available for sale 0 (30,586)
Sale and maturity of debt securities, available for sale 0 79,161
Net cash (used in)/provided by investing activities (27,504) 14,586
Cash flows from financing activities
Proceeds from issuance of Common Stock 33,462 38,110
Payments on related party revenue bonds (535) (475)
Payment to purchase revenue bonds 0 (253,230)
Proceeds from exercise and issuance of warrants 6,616 30,050
Proceeds from equipment lease financing 0 9,536
Payments on equipment financing (7,663) (3,118)
Preferred stock and debt issuance costs (7,624) (1,119)
Payments to repurchase shares (4,527) (1,178)
Other financing activities 698 1,122
Net cash provided by/(used in) financing activities 347,298 (110,462)
Net increase/(decrease) in cash and restricted cash 205,742 (208,861)
Cash and cash equivalents and restricted cash, beginning of period 41,511 302,514
Cash and cash equivalents and restricted cash, end of period 247,253 93,653
Operating Activities
Interest paid during the period 29,247 33,786
Non-cash financing activities
PIK dividends on Series B Convertible Perpetual Preferred Stock 5,900 -
Carrying value of shareholder loan exchanged for revenue bonds payable to related parties 0 44,386
Initial fair value of warrant liability issued to satisfy shareholder loan prepayment penalty 0 6,802
Reconciliation of cash and cash equivalents and restricted cash reported in the consolidated balance sheet
Cash and cash equivalents 234,359 83,673
REstricted cash - current 3,582 241
Restricted cash - noncurrent 9,312 9,739
Total cash, cash equivalents and restricted cash 247,253 93,653
Series A Preferred Stock
Cash flows from financing activities
Proceeds from issuance of Series A Preferred shares, inclusive of put option 0 21,840
Non-cash financing activities
PIK interest 3,005 0
Series B Convertible Perpetual Preferred Stock
Non-cash financing activities
PIK dividends on Series B Convertible Perpetual Preferred Stock 5,927 0
Series B
Cash flows from financing activities
Proceeds from issuance of Series B Convertible Perpetual Preferred Stock 300,000 0
Third Party
Cash flows from financing activities
Proceeds from issuance of revenue bonds 16,808 8,000
Related Party
Cash flows from financing activities
Proceeds from issuance of revenue bonds 16,063 40,000
Proceeds from revolving credit facility and related party note payable 14,900 0
Payments on revolving credit facility and related party note payable (14,900) 0
Accounts Payable and Accrued Expenses
Non-cash investing activities
Additions to property, plant, and equipment 13,466 19,546
Related Party Notes Payable
Non-cash investing activities
PK interest $ 0 $ 1,938
(1,779) (347)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
Sep. 30, 2025 Sep. 30, 2024
Cash flows from operating activities
Net loss $ (163,778) $ (224,458)
Adjustments to reconcile net loss to net cash used in operating activities
Equity-based compensation 12,668 8,637
Change in fair value of warrants 1,881 54,532
Change in fair value of derivative (3443) 395
Depreciation expense 21,875 23,853
Amortization of debt issuance costs and debt discounts 17,335 10,505
Accretion of discount on debt securities 0 (330)
Operating lease amortization expense 3,398 2,281
Loss on extinguishment of debt 0 21,214
Loss on disposal of equipment 3,765 0
Impairment of operating right-of-use asset 0 757
Other 938 0
Changes in operating assets and liabilities
Accounts receivable (1,595) 0
Inventory (2,638) (1,829)
Prepaid expenses and other current assets
Prepaid expenses and other noncurrent assets 968 (63)
Accounts payable (2,062) 675
Accrued expenses and other current liabilities (578) (3,379)
Accrued interest 1,820 (3,334)
Other noncurrent liabilities 0 359
Net cash used in operating activities (96,359) (143,160)
Cash flows from investing activities
Additions to property, plant, and equipment -70752 -62325
Proceeds from sale of property, plant and equipment 0 1681
Additions to intangible assets -350 0
Change in restricted cash 87 -126
Net cash used in investing activities -71015 -60770
Cash flows from financing activities
Proceeds from issuance of Series B Convertible Perpetual Preferred Stock 300000 0
Proceeds from issuance of revenue bonds 26871 48000
Proceeds from revolving credit facility and related party note payable 14900 0
Payments on revolving credit facility and related party note payable -14900 0
Proceeds from issuance of Series A Preferred shares, inclusive of put option 0 21840
Proceeds from issuance of common stock and warrants, net of offering costs 0 89000
Proceeds from the exercise of stock options and warrants 89 16
Payments on finance lease obligations -2979 -1834
Payments on debt -10178 -3746
Deferred financing costs -282 0
Net cash provided by financing activities 313821 153276
Effect of exchange rate changes on cash, cash equivalents and restricted cash -24 -27
Net increase (decrease) in cash, cash equivalents and restricted cash 146423 -50681
Cash, cash equivalents and restricted cash at beginning of period 93653 144334
Cash, cash equivalents and restricted cash at end of period 240076 93653
Supplemental Disclosures of Cash Flow Information
Cash paid during the period for interest, net of capitalized interest 35919 13835
Non-cash investing activities
Additions to property, plant, and equipment 13466 14275
Additions to intangible assets 50 0
Non-cash financing activities
Issuance of common stock upon vesting of restricted stock units 1778 1148
Issuance of common stock to satisfy accrued interest 3602 0
Issuance of warrants and common stock for services 0 1068
Initial fair value of warrant liability issued to satisfy shareholder loan prepayment penalty 0 6802
Issuance of Series A Preferred Stock to extinguish bonds payable to related parties 0 44386
PIK interest 3005 0
PIK dividends on Series B Convertible Perpetual Preferred Stock 5927 0
Reconciliation of cash and cash equivalents and restricted cash reported in the consolidated balance sheet
Cash and cash equivalents 234359 83673
Restricted cash - current 3582 241
Restricted cash - noncurrent 9312 9739
Total cash, cash equivalents and restricted cash 247253 93653
Series A Preferred Stock
Cash flows from financing activities
Interest paid during the period 0 21840
Non-cash financing activities
PIK interest 3005 0
Series B Convertible Perpetual Preferred Stock
Non-cash financing activities
PIK dividends on Series B Convertible Perpetual Preferred Stock 5927 0
Series B
Cash flows from financing activities
Proceeds from issuance of Series B Convertible Perpetual Preferred Stock 300000 0
Third Party
Cash flows from financing activities
Proceeds from issuance of revenue bonds 16808 8000
Related Party
Cash flows from financing activities
Proceeds from issuance of revenue bonds 10063 40000
Proceeds from revolving credit facility and related party note payable 14900 0
Payments on revolving credit facility and related party note payable -14900 0
Accounts Payable and Accrued Expenses
Non-cash investing activities
Additions to property, plant, and equipment 13466 14275

Source

-